fbpx

WuXi to build dedicated vaccine facility, but who’s the client?

WuXi to build dedicated vaccine facility, but who’s the client?

WuXi Biologics says its vaccine joint venture has a new client and a 20-year arrangement it says should be worth about $3 billion. (WuXi Biologics).

May 24, 2019 / Pharma News
X
Send a message
Request a call

* Required fields

By submitting this form you confirm that you have read and accepted our privacy policy. Your data will be used exclusively for this purpose.

* Required fields

By submitting this form you confirm that you have read and accepted our privacy policy. Your data will be used exclusively for this purpose.

X